The use of a non-medicated dressing for superficial-partial thickness burns in children: a case series and review

Abstract

Background: Cutimed® Sorbact® is a dressing marketed as having antimicrobial properties and easy application without the threat of antibiotic resistance and difficult accessibility. There is little evidence on the clinical outcomes of the use of Cutimed® Sorbact® in adults and currently no evidence of use of Cutimed® Sorbact® on superficial-partial thickness burn injuries in children. Objective: To summarise the clinical outcome of burn wounds in children with superficial-partial thickness burns in which Cutimed® Sorbact® was used. Method: An observational case series was conducted in Edendale Hospital, Pietermaritzburg, South Africa over the course of four weeks. Patients where included if they were aged < 10 years and had a ⩽ 15% superficial-partial burn. The primary outcome measure was time to 95% re-epithelialisation. Secondary outcome measures included wound complications, adverse healing and number of dressing changes. Results: Ten patients (five girls, five boys; age range = 11 months–8 years) were included in this case series. All participants had a type VI Fitzpatrick skin type and 80% of burns were hot water burns. Of all patients treated with Cutimed® Sorbact®, 50% healed within seven days, 70% within 14 days and 100% within 21 days. There was only one wound complication noted in this study and there was no adverse healing in any burn wounds. The mean number of dressing changes was 1.4 (range = 1–2) and length of hospital stay was in the range of 0–11 days (mean = 5.1 days). Conclusion: Cutimed® Sorbact® is a safe, useful and cost-effective dressing that should be used as an alternative for superficial-partial burns in children.

Meeting the Challenges in Pediatric Wound Care: Our 15-Year Experience with Dialkylcarbamoyl Chloride-Coated Dressing Technology in Acute and Chronic Wounds

“…DACC wound dressing has also been used in the treatment of first, second and third degree burns in patients of pediatric age, reducing re-epithelialisation times with minimal psychological distress and no side effects in a group of ten patients. 58 In our experience, DACC wound dressing is extremely effective in the treatment of burns of the extremities, where it prevents the scar fusion of the digits, controls pain and reduces the appearance of interphalangeal keloids.…”

“…A small observational case series in 10 children (mean age = 2.49 years, range 11 months -8 years) with superficial-partial burns (TBSA range 4-14%, mean = 8%) showed that DACC wound dressing was effective at promoting wound progression in these burn wounds, with 50% of wounds healing within seven days and 100% of wounds healing within 21 days. 58 Few clinical studies have examined the effect of DACC wound dressings on the incidence of wound infection. Meberg and Schøyen 59 reported on umbilical cord care and prevention of infection in a large prospective randomised trial of 2441 infants who received either DACC wound dressing or daily cleansing of the wound with 0.5% chlorhexidine/70% ethanol.…”

To compare the effect of sea buckthorn and silver sulfadiazine dressing on period of wound healing in patients with second‐degree burns: A randomized triple‐blind clinical trial

“…9 The use of traditional medicines as a safe, affordable and simpleto-use approach with limited side effects these days is becoming reconsidered in different countries. 10 Sea buckthorn is of evergreen plants grown mostly in a moderate climate and at high altitudes in many parts of the world, including Europe and Asia. 11 Sea buckthorn has been applied as a topical medicine for wound repairing in some traditional medicine methods.…”

The role of b1 methylation, physiologic replication independent endogenous dna double strand breaks (phy-rind-edsb) and laminin 511 e8 proteins in rat second degree burn wound healing

“…(Deutzmann et al, 1990;Taniguchi et al, 2009) Thus, although LM511-E8 is substantially smaller (~150 kDa) than the full-length protein (~800 kDa), it serves as a functionally minimal form of LM511 and retains the key characteristics of the full-length protein including integrinbinding and dystroglycan binding sites that support adhesion and migration. (Doi et al, 2002;Kumai et al, 2019;T. Miyazaki et al, 2012;Y.…”